中西医结合治疗中老年广泛性焦虑症临床研究被引量：3

Clinical Study of Treatment of Middle-Aged and Elderly Patients with Generalized Anxiety by Chinese and Western Medicine

下载PDF

导出

摘要目的 :观察六味地黄丸与奥氮平联合治疗中老年肾阴虚型广泛性焦虑症的临床疗效。方法 :选择中老年肾阴虚型广泛性焦虑症患者96例,随机分为治疗组50例、对照组46例。对照组采用心理疏导及舍曲林治疗,治疗组在此基础上加用六味地黄丸与奥氮平联合治疗,两组疗程均为24周。比较两组治疗前后汉密尔顿焦虑量表评分、血浆C反应蛋白(CRP)、血浆超氧化物歧化酶(SOD)、血管紧张素II(Ang II)水平及颈内动脉内中膜厚度(IMT)变化情况。结果:治疗后两组血浆CRP、SOD、Ang II水平、汉密尔顿焦虑量表(HAMA)评分及颈内动脉内中膜厚度有显著性差异(P<0.05),治疗组血浆CRP、Ang II水平、HAMA评分及颈内动脉内中膜厚度均低于对照组(P<0.05),治疗组血浆SOD高于对照组(P<0.05);临床疗效治疗组优于对照组(P<0.05)。结论:六味地黄丸与奥氮平联合治疗中老年肾阴虚型广泛性焦虑症临床疗效理想。 Objective：To observe the curative effect of olanzapine combined with Liuwei Dihuang pill on generalized anxiety in middle-aged and elderly patients with kidney yin deficiency syndrome. Methods：Nine-ty-six middle-aged and elderly patients with kidney yin deficiency syndrome and generalized anxiety were randomly divided into treatment group （n=50） and control group （n=46）. Patients in the control group were treated with mental nursing and sertraline for 24 weeks. Patients in the treatment group ,on basis of the control group,were added with olanzapine and Liuwei Dihuang Pill for 24 weeks. Before and after treatment,the blood samples were taken to test the C reactive protein（CRP）,angiotensin（AngII）,superoxide dismutase（SOD）,Hamilton anxiety（HAMA） scores and the carotid artery intima-media thickness IMT. Results：After treatment,there were significant differences in CPR,SOD,AngII,HAMA scores and IMT of the two groups. The CRP level,AngII level,HAMA scores and Carotid artery IMT of the treatment group were lower than those of the control group and the SOD level was higher than that of the control group. The clinical curative effect of the treatment group was better than that of the control group. Conclusion：The therapeutic effect of olanzapine combined with Liuwei Dihuang Pill on generalized anxiety in middle-aged and elderly patients with kidney yin deficiency syndrome is significant.

作者张敏宋开兰庞月玖任爱玲

机构地区山东中医药大学山东省立医院

出处《山东中医药大学学报》 2015年第5期422-424,共3页 Journal of Shandong University of Traditional Chinese Medicine

关键词广泛性焦虑症六味地黄丸奥氮平 C反应蛋白血管紧张素Ⅱ 超氧化物歧化酶颈内动脉内中膜厚度 generalized anxiety Liuwei Dihuang pill olanzapine CRP AngII SOD carotid artery intima-media thickness

分类号 R277.797.2 [医药卫生—中医学]

引文网络
相关文献

参考文献10

1中华医学会精神科分会.中国精神障碍分类与诊断标准[M].济南:山东科学技术出版社,2001.75-90.
2Connor K M ,Davidson J R T. The neurobiology of generalized anxiety disorder[J]. Bid Psychiatry,1998 ,44 :1284.
3李献云.奥氮平在体内外的生物化学[J].国外医药（合成药．生化药．制剂分册）,1998,19(6):352-354. 被引量：2
4Invernizzi R W,Garattini S. Role of presynaptie alpha2-adreno- ceptors in antidepressant action:recent findings from microdialysis studies[J]. Prog Neuropsyehopharmaeol Biol Psyehiatry,2004,28 (5) :819-827.
5Lorenz M W,Markus H S,Bots M L,et al. Prediction of clinical cardiovascular events with carotid intima-media thickness :a sys- tematic review and meta-analysis [ J ]. Circulation, 2007,115 (4) : 459-467.
6Sebwarzer R,Sehuell-Inderst P,Grabein K,et al. Prognostic yalue and clinical effectiveness of high sensitivity C-reactive protein as a marker in primary prevention of major cardiac events[J]. Z Evid Fortbid Qual Gesundhwes,2009,103(6):319-329.
7Trujill o M,Radi R. Peroxynitrite reaction with the reduced and the oxidized forms of lipoic acid:new insights into the reaction of peroxynitrite with thiolos[J]. Arch Biochem Biophy,2002,397 (1) :91-98.
8Zefen Wanga,Hong Yanga,Aramandla Rameshb,et al. Over exp- ression of Cu/Zn-superoxide dismutase and/orcatalase accelerates benzo pyrene dctoxification by upregulation of the arylhydroear- bon receptor in mouseendothelial cells[J]. Free Radic Biol Med, 2009,47(8) : 1221-1229.
9杨智华,杨丽霞,郭瑞威,齐峰,石燕昆,王红,叶金善,梁星.血管紧张素Ⅱ对载脂蛋白E敲除小鼠主动脉粥样硬化斑块细胞外基质金属蛋白酶诱导因子表达影响[J].中国动脉硬化杂志,2010,18(11):861-864. 被引量：3
10薛耀明,朱波,罗仁.六味地黄丸在糖尿病治疗中的应用与研究[J].现代中西医结合杂志,2005,14(14):1925-1927. 被引量：10

二级参考文献39

1张汝学,顾国明,张永祥,周金黄.地黄低聚糖对实验性糖尿病与高血糖大鼠糖代谢的调节作用[J].中药药理与临床,1996,12(1):14-17. 被引量：49
2Virmani R, Burke AP, Farb A. Pathology of the vulnerable plaque [ J ]. JAm Coll Cardiol, 2006, 47 (6) : c13-18.
3Browatzki M, LarsenD, Pfeiffer CA. Angiotensin II stimulates matrix metalloproteinase secretion in human vascular smooth muscle cells via nuclear factor- KB and activator protein 1 in a redox-sensitive manner [ J ]. J Vasc Res, 2005, 42 (5): 415-423.
4Yoon YW, Kwon HM, Hwang KC, et al. Upstream regulation of matrix metalloproteinase by EMMPRIN; extracellular matrix metalloproteinase inducer in advancedatherosclerotic plaque [ J]. Atherosclerosis , 2005, 180 (1): 37-44.
5Guo RW, Yang LX, Wang H. Angiotensin II induces matrix metalloproteinase-9 expression via a nuclear factor-kappaB-dependent pathway in vascular smooth muscle cells [ J ]. Regul Pept, 2008, 147 ( 1-3 ) : 37-44.
6Rosenfeld ME, Polinsky P, Virmani R, et al. Advanced atherosclerotic lesions in the innominate artery of the apoe knockout mouse [ J ]. Arterioscler Thromb Vasc Biol, 2000, 20 (12): 2 587-592.
7Johnson JL, Jackson CL. Atherosclerotic plaque rupture in the apolipoprotein E knockout Mouse [J]. Atherosclerosis, 2001, 154 (2) : 399-406.
8Newby AC. Metalloproteinase expression in monocytes and maerophages and its relationship to atherosclerotic plaque instability [ J ]. Arterioscler Thromb Vasc Biol, 2008, 28 (12): 2 108-114.
9Koenig W, Khuseyinova N. Biomarkers of atherosclerotic plaque instability and rupture [ J ]. Arterioscler Thromb Vasc Biol, 2007, 27 ( 1 ) : 15- 26.
10Lucia M, Duchosal MA, Korber M. Endogenous angiotensin II induces atherosclerotic plaque vulnerability and elicits a Th1 response in ApoE-/- mice [ J]. Hypertension, 2004, 44 (3) : 277-282.